Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121913500
rs121913500
IDH1
0.010 GeneticVariation BEFREE This study demonstrates that IDH1 R132H mutation with increased oncometabolite R-2HG in PCa cells may play important roles to increase PCa cell invasion. 31846689

2020
dbSNP: rs772893086
rs772893086
ADARB1
0.010 GeneticVariation BEFREE This study demonstrates that IDH1 R132H mutation with increased oncometabolite R-2HG in PCa cells may play important roles to increase PCa cell invasion. 31846689

2020
dbSNP: rs3181082
rs3181082
CD1B
0.010 GeneticVariation BEFREE Our results indicated that <i>CD1B</i> rs3181082 confers prostate cancer progression and may help improve clinical prognostic stratification. 31783478

2019
dbSNP: rs10993994
rs10993994
MSMB
0.800 GeneticVariation BEFREE This study demonstrated a significant association between the MSMB rs10993994 polymorphisms and PCa risk. 31773691

2019
dbSNP: rs2297441
rs2297441
TNFRSF6B ; RTEL1 ; RTEL1-TNFRSF6B
0.010 GeneticVariation BEFREE <i>RTEL1</i> rs2297441 [odds ratio (OR): 1.23; 95% confidence interval (CI): 1.03-1.46, <i>P</i> = 0.021] and rs3208008 (OR: 1.23; 95% CI: 1.03-1.46) were associated with PCa risk. 31762827

2019
dbSNP: rs3208008
rs3208008
TNFRSF6B ; RTEL1 ; RTEL1-TNFRSF6B
0.010 GeneticVariation BEFREE <i>RTEL1</i> rs2297441 [odds ratio (OR): 1.23; 95% confidence interval (CI): 1.03-1.46, <i>P</i> = 0.021] and rs3208008 (OR: 1.23; 95% CI: 1.03-1.46) were associated with PCa risk. 31762827

2019
dbSNP: rs4073
rs4073
CXCL8
0.050 GeneticVariation BEFREE The major findings of this meta-analysis suggested that IL-8 rs4073 polymorphism is significantly associated with risk of prostate cancer. 31718853

2019
dbSNP: rs486907
rs486907
RNASEL
0.100 GeneticVariation BEFREE CONCLUSIONS We report the effect of rs627928 on the development of prostate cancer and confirm that rs486907 is not involved in the risk of prostate cancer in the current meta-analysis. 31686670

2019
dbSNP: rs627928
rs627928
RNASEL
0.080 GeneticVariation BEFREE Nevertheless, rs627928 was reported to promote the development of prostate cancer (T vs. G: OR=1.08, 95% CI=1.01-1.15; TT+TG vs. GG: OR=1.14, 95% CI=1.03-1.25) in allele and recessive models in overall populations. 31686670

2019
dbSNP: rs145204276
rs145204276
GAS5 ; ZBTB37 ; SNORD74 ; SNORD75 ; SNORD76 ; SNORD77 ; SNORA103
0.020 GeneticVariation BEFREE We aimed to investigate the effect of variant rs145204276 of GAS5 on the prostate cancer susceptibility and clinicopathologic characteristics. 31673232

2019
dbSNP: rs851023
rs851023
MAPK14
0.010 GeneticVariation BEFREE The MAPK14 gene SNP rs851023 was associated with PCa and aggressive PCa risk after multiple comparison adjustment. 31667711

2019
dbSNP: rs13426236
rs13426236
MLPH
0.010 GeneticVariation BEFREE This study provides strong evidence showing that prostate cancer risk SNP rs13426236 upregulates expression of MLPH transcript V4, which may function as a candidate oncogene in prostate cancer. 31659808

2020
dbSNP: rs662
rs662
PON1
0.020 GeneticVariation BEFREE <b>Conclusions:</b> We reported by the first time a correlation between rs662 (PON1) and PCa aggressiveness. 31647334

2019
dbSNP: rs35672330
rs35672330
EXO5
0.010 GeneticVariation BEFREE We found two other EXO5 SNPs significantly associated with risk of PCa in cases-controls study from databases of genotype and phenotype (dbGaP), which are in linkage disequilibrium (D' = 1) with Exo5 L151P found in PCa family. 31616062

2020
dbSNP: rs919467999
rs919467999
ERG
0.010 GeneticVariation BEFREE We found two other EXO5 SNPs significantly associated with risk of PCa in cases-controls study from databases of genotype and phenotype (dbGaP), which are in linkage disequilibrium (D' = 1) with Exo5 L151P found in PCa family. 31616062

2020
dbSNP: rs10993994
rs10993994
MSMB
T 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs1447295
rs1447295
CASC8
A 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs16901979
rs16901979
PCAT1 ; CASC19
A 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs2735839
rs2735839 		G 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs4430796
rs4430796
HNF1B
A 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs6983267
rs6983267
POU5F1B ; CASC8 ; PCAT1 ; CCAT2
G 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs339331
rs339331
RFX6
T 0.760 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs12653946
rs12653946
CTD-2194D22.4
T 0.740 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs11649743
rs11649743
HNF1B ; LOC105371754
G 0.730 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019
dbSNP: rs1465618
rs1465618
THADA
T 0.720 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019